Cargando…

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

The long-term storage stability of vaccines has a major impact on the roll-out and success of global immunization programs. For the Human Immunodeficiency Virus type 1 (HIV-1) virus-like particle (VLP) vaccine prototype evaluated here, nanoparticle tracking analysis (NTA), and enzyme-linked immunoab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguado-Garcia, Diana, Olvera, Alex, Brander, Christian, Sanchez-Merino, Victor, Yuste, Eloisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029469/ https://www.ncbi.nlm.nih.gov/pubmed/35455233 http://dx.doi.org/10.3390/vaccines10040484

Ejemplares similares

Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
por: Beltran-Pavez, Carolina, et al.
Publicado: (2022)

Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant
por: Beltran-Pavez, Carolina, et al.
Publicado: (2018)

Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation
por: Kadji, Francois Marie Ngako, et al.
Publicado: (2022)

Enveloped and non-enveloped viral-like particles in Trypanosoma cruzi epimastigotes
por: Fernández-Presas, Ana María, et al.
Publicado: (2017)

Searching for Axion Like Particles with the MADMAX prototype
por: Majorovits, B, et al.
Publicado: (2019)

HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity
por: Pernas, Maria, et al.
Publicado: (2015)

Low-Replicating Viruses and Strong Anti-Viral Immune Response Associated with Prolonged Disease Control in a Superinfected HIV-1 LTNP Elite Controller
por: Pernas, María, et al.
Publicado: (2012)

Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions
por: Llano, Anuska, et al.
Publicado: (2013)

Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides
por: Caldeira, Jerri C, et al.
Publicado: (2011)

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
por: Müller, Helena, et al.
Publicado: (2020)

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
por: Aldon, Yoann, et al.
Publicado: (2018)

Size-selective downstream processing of virus particles and non-enveloped virus-like particles
por: Hillebrandt, Nils, et al.
Publicado: (2023)

Bioorthogonal Strategy for Bioprocessing of Specific-Site-Functionalized Enveloped Influenza-Virus-Like Particles
por: Carvalho, Sofia B., et al.
Publicado: (2016)

Thermal Module prototype Evaluation
por: Apsimon, R, et al.
Publicado: (1998)

Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens
por: Schiffner, Torben, et al.
Publicado: (2015)

Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus
por: Harahap-Carrillo, Indira S., et al.
Publicado: (2015)

Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
por: Olvera, Alex, et al.
Publicado: (2021)

Dry Formulation of Virus-Like Particles in Electrospun Nanofibers
por: Dowlath, Sasheen, et al.
Publicado: (2021)

Assembly of Viruses: Enveloped Particles
por: Navaratnarajah, C.K., et al.
Publicado: (2008)

Stability studies of HIV-1 Pr55(gag) virus-like particles made in insect cells after storage in various formulation media
por: Lynch, Alisson, et al.
Publicado: (2012)

Structure of Turnip mosaic virus and its viral-like particles
por: Cuesta, Rebeca, et al.
Publicado: (2019)

Isothermal microcalorimetry for thermal viable count of microorganisms in pure cultures and stabilized formulations
por: Nykyri, Johanna, et al.
Publicado: (2019)

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
por: Metz, Stefan W., et al.
Publicado: (2018)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017)

Stabilized diverse HIV-1 envelope trimers for vaccine design
por: Wang, Qian, et al.
Publicado: (2020)

The Thermal Performance of Forward SCT Module Prototypes
por: Freestone, J, et al.
Publicado: (1999)

A Rapid Prototyped Thermal Mass Flowmeter
por: Pečar, Borut, et al.
Publicado: (2021)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
por: Chapman, Rosamund, et al.
Publicado: (2020)

SLS: Pushing the Envelope Based on Stability
por: Aiba, M., et al.
Publicado: (2013)

The stability of envelope-pseudotyped lentiviral vectors
por: Dautzenberg, Iris J. C., et al.
Publicado: (2020)

Conformational and Thermal Stability Improvements for the Large-Scale Production of Yeast-Derived Rabbit Hemorrhagic Disease Virus-Like Particles as Multipurpose Vaccine
por: Fernández, Erlinda, et al.
Publicado: (2013)

Characterization and stabilization in process development and product formulation for super large proteinaceous particles
por: Yang, Yanli, et al.
Publicado: (2020)

Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes.
por: Vennema, H, et al.
Publicado: (1996)

Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages
por: Stantchev, Tzanko S., et al.
Publicado: (2019)

Virus-like particles with FLAG-tagged envelope protein as a tetravalent dengue vaccine candidate
por: Imagawa, Toshifumi, et al.
Publicado: (2021)

Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
por: Schiffner, Torben, et al.
Publicado: (2018)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Assessing Multi-Attribute Characterization of Enveloped and Non-Enveloped Viral Particles by Capillary Electrophoresis
por: Fernandes, Rita P., et al.
Publicado: (2022)

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
por: Fluckiger, Anne-Catherine, et al.
Publicado: (2021)

Induction of humoral and cellular immune responses against the HIV-1 envelope protein using γ-retroviral virus-like particles
por: Kirkegaard, Tea, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9n1b05mgqaduobsq13ij2fnla0